GGrantIndex
Sort

78,016 grants matching breast cancer

Effect and Mechanism of Acupuncture for Cancer-related Cognitive Impairment (ENHANCE)

$708,599
Jun J Mao · Sloan-Kettering Inst Can Research · R01 · FY2023 · CA

Polarized Probe for Fiberoptic In-Vivo Spectroscopy

$708,574
Randal B Chinnock · Optimum Technologies, Inc. · R44 · FY2006 · CA

IL-2 Family Cytokines and their Receptors--Biology of the IL-7/TSLP Systems

$708,555
Warren J Leonard · National Heart, Lung, And Blood Institute · ZIA · FY2025 · HL

Disruption of parity-induced tumor suppressor pathways by xenoestrogen exposures

$708,450
D Joseph Jerry · University Of Massachusetts Amherst · U01 · FY2019 · ES

Personalizing genetic test results management and outcomes after diagnosis of cancer: the Georgia-California SEER Genelink Study

$708,444
Allison W. Kurian · Stanford University · R01 · FY2024 · CA

The Molecular Profile of Prostate Tumors in African-American Men

$708,426
Stefan Ambs · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA

Integrated PET+DBT for optimization of breast cancer therapy

$708,325
Paul E Kinahan · University Of Washington · U01 · FY2024 · EB

REDUCTION OF TRIGLYCERIDES IN WOMEN ON HRT

$708,215
University Of Pittsburgh At Pittsburgh · R01 · FY2001 · HL

Development of a platform for spatial functional genomics

$707,878
Brian D Brown · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · AT

PROPHYLACTIC SURGERY IN CARRIERS OF BRCA1 AND BRCA2

$707,790
University Of Pennsylvania · R01 · FY2002 · CA

CCTN - CONTRACEPTIVE EFFICACY AND SAFETY OF DAILY ORAL ULIPRISTAL ACETATE

$707,782
Erin Allen · Eastern Virginia Medical School · N01 · FY2013 · HD

Novel Therapeutic Targets for Venous Thromboembolism

$707,638
Thomas William Wakefield · University Of Michigan At Ann Arbor · R01 · FY2012 · HL

Genetic and environmental interaction analyses and risk prediction modeling

$707,617
Thomas A Sellers · H. Lee Moffitt Cancer Ctr & Res Inst · U19 · FY2012 · CA

Olfactomedin 4 Suppresses Prostate Cancer Cell Growth and Metastasis via Negativ

$707,429
Griffin Rodgers · National Heart, Lung, And Blood Institute · ZIA · FY2012 · HL

Population Modeling of Bladder Cancer Detection and Control

$707,395
Thomas Trikalinos · Brown University · U01 · FY2021 · CA

Transplant Models

$707,370
Ronald Gress · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA

Fat Reduction, HRT Use and Benign Breast Disease Risk

$707,333
Yeshiva University · R01 · FY2003 · CA

Neurocognitive and Patient-Reported Outcomes after Chimeric Antigen Receptor T-Cell Therapy: A Controlled Comparison

$707,291
Heather S.l. Jim · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2022 · CA

Phase II Clinical Trial of Polyphenon E in Prostate Cancer

$707,275
Nagi B Kumar · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2009 · CA

Ultrasound imaging and local drug delivery in tumors

$707,248
Katherine W Ferrara · University Of California At Davis · R01 · FY2011 · CA

SENTINEL NODE IN BREAST CONSERVING THERAPY

$707,240
University Of Vermont &St Agric College · U01 · FY2000 · CA

(PQC3) Ethnicity-determined immune response and DCIS outcome

$707,173
Sunil S. Badve · Indiana University Indianapolis · R01 · FY2015 · CA

A Genetic Linkage Study of Testicular Cancer

$707,172
Victoria K Cortessis · University Of Southern California · R01 · FY2007 · CA

Impact of Cellular and Extracellular Host Components on Tumor Progression

$707,171
Richard O Hynes · Massachusetts Institute Of Technology · U54 · FY2014 · CA

Alameda County Network Program for Reducing Cancer Disparities

$707,057
Joan R Bloom · University Of California Berkeley · U54 · FY2014 · CA